Objective: To investigate the network pharmacology of Shexiang Baoxin pill (SBP) and systematically analyze the mechanisms of SBP. Methods: In this study, we excavated all the targets of 26 constituents of SBP which were identified in rat plasma though literature mining and target calculation (reverse docking and similarity search) and analyzed the multiple pharmacology actions of SBP comprehensively through a network pharmacology approach. Results: In the end, a total of 330 Homo sapiens targets were identified for 26 blood constituents of SBP. Moreover, the pathway enrichment analysis found that these targets mapped into 171 KEGG pathways and 31 of which were more enriched. Among these identified pathways, 3 pathways were selected for analyzing the mechanisms of SBP for treating coronary heart disease. Conclusion: This study systematically illustrated the mechanisms of the SBP by analyzing the corresponding "drug-target-pathway-disease" interaction network.
IntRoductIon
Compared with Western medicine which generally prescribes the treatments for specific diseases on the basis of their physiological cause, traditional Chinese medicine (TCM) focuses on the balance of a whole body involving a complex interaction of physical, spiritual, mental, emotional, genetic, and environmental factors. [1] Moreover, use the herb formula developed from the theories of Jun-Chen-Zuo-Shi to modulate the whole body from imbalance to balance. The Jun (emperor) herbs treat the main cause or primary symptoms of a disease. The Chen (minister) herbs serve to augment or broaden the effects of Jun and relieve secondary symptoms. The Zuo (assistant) herbs are used to modulate the effects of Jun and Chen and to counteract the toxic or side effects of these herbs. The Shi (courier) herbs are included in many formulae to ensure that all components in the prescription are well absorbed and to help deliver or guide them to the target organs. [2] Only those formulae under its synergistic principle can work effectively on the whole body. Therefore, the TCM plays function as a synergy way. From the molecule level, the TCM shows a new "multicomponent, network target" model compared with "one target, one drug" model of Western medicine. [3] Shexiang Baoxin pill (SBP) is one of the classical TCMs [4] and has been widely used in the clinic for 30 years and The complication of TCM composition makes it hard to analyze the mechanism based on the whole composition. The concept of serum pharmacology based on the hypothesis that active compounds could be absorbed into blood after administration of TCM and only the absorbed components have the chance to show the effects. [13] This strategy has been used to screen the bioactive components from TCM, which contains complicated components and become a very straightforward and helpful method for discovering real bioactive constituents in TCM. [14] [15] [16] Here, to explore the mechanism of action of SBP from a holistic perspective, the network pharmacology method was employed to investigate the molecular behavior of 26 constituents of SBP which were identified in plasma [ Figure 1 ]. [17] Among the 26 constituents of SBP, compound 5 is a metabolite of cholic acid (compound 6). [17] The sources of these compounds have been shown in Table 1 . We collected all available target information for 26 plasma constituents through literature mining and computational prediction (three-dimensional [3D] similarity search and reverse docking) to construct a network of the "drug-target-pathway-disease" interactions. By integrating these interactions, we found that the SPB exerts the function of the treatment of cardiovascular disease through the modulation of multiple pathways by its plasma constituents, which is in accordance with the "multicomponent, network target" model [ Figure 1 ]. obtains satisfactory therapeutic effects for coronary heart disease. [5] The SBP consists of seven medicinal materials including Moschus, Radix Ginseng, Calculus Bovis, Cortex Cinnamomi, Styrax, Venenum Bufonis, and Borneolum Syntheticum. In which, the Moschus is Jun herb, the Radix Ginseng and Calculus Bovis are Chen herb, the Cortex Cinnamomi, Styrax, and Venenum Bufonis are Zuo herb, and the Borneolum Syntheticum is Shi herb. Some papers revealed certain mechanism-related cardiovascular diseases, such as pharmacological studies showed that SBP can promote the function of endothelial progenitor cell, [6] induce CYP3A, [7] increase the level of NO (nitric oxide), [8] reduce myocardial fibrosis in spontaneously hypertensive rats, [9] and so on. However, a systematical and comprehensive analysis based on the "multicomponent, network target" model is missing.
An herbal formula is a complicated chemical system involving a mixture of many types of chemical compounds which correlated with multiple targets. Thereby, herb formulas are considered to act on the "Network target" of specific disease. [10] Network pharmacology invokes the idea that a drug engages with multiple targets and rarely interacts with a single protein in isolation and updates the research paradigm from the current "one target, one drug" model to a new "multicomponent, network target" model. [11] This approach utilizes principles of systems biology and network analysis to interpret the mechanism of drugs in a complex disease, which is aligned with the theoretical significance of the herbal formula. [12] Figure 1: Twenty-six constituents of Shexiang Baoxin pill which were identified in plasma (Compounds 25 is a metabolite)
Methods

Data preparation
Target information collection by literature mining: All available information on the targets of 26 plasma constituents in the literature were collected by searching PubMed using the structure search and comparative toxicogenomics database (CTD, http://www.ctdbase.org/about/) which contains chemical-gene/protein interactions in vertebrates and invertebrates from the published literature. Only the confirmed and active targets were selected from the research results.
Identification of putative protein targets for 26 plasma constituents of SBP: The method of similarity searching and reverse docking was used to predict the putative protein targets for 26 plasma constituents of SBP. For the similarity search, the online web server ChemMapper, [18] which is based on the 3D similarity procedure SHAFTS, used to predict the potent targets according to the similar score. SHAFTS provides a ShapeScore (based on the shape overlap) and a FeatureScore (based on the pharmacophore fit), and the weighted sum of the two scores is considered the hybrid similarity HybridScore. [19] A higher HybridScore implies a better alignment in terms of both shape and chemotype identities between the query and target molecules. [20] In this study, the targets with a HybridScore value higher than 1.500 were selected as potent targets. For the reverse docking, the free web server PharmMapper was used to predict the potent targets according to Fit Score value. [21, 22] In this study, the cutoff Fit Score value was set to 4.000. The targets with a Fit Score value higher than 4.000 were selected as potential targets.
Coronary heart disease drugs and therapeutic targets: The file "drugbank.xml" that contains all the FDA-approved drugs and targets were downloaded from the DrugBank database and searched by the keywords "cardiovascular," "heart," "coronary heart disease," "myocardial." All related drugs and targets were exported and listed to a new file. This process was performed by the Python script.
Network construction and analysis
Protein-protein interaction network: The individual interaction networks for each protein were built by the use of the STRING database which is the integration of known and predicted protein interactions. [23] The network interactions were selected according to STRING-computed confidence scores (medium confidence 0.4000). The Cytoscape is an open source software platform for visualizing molecular interaction networks and developed by the program Cytoscape (Version 2.8.3, developed by Cytoscape Consortium, http://www.cytoscape.org/) and the Network Analyzer plugin (version:3.3.2, developed by Cytoscape Consortium, The National Institute of General Medical Sciences is the sponser, http://apps.cytoscape.org/apps/networkanalyzer) were used to visualize the network and calculate the basic network parameters including the degree of distribution, degree exponent, shortest path length distribution, and clustering coefficient.
Drug-target interaction network: For the coronary heart disease-related drugs and targets, a protein node and a drug node are linked if the protein is targeted by that specific drug according to the DrugBank information. For the 26 plasma constituents of SBP, a link was built between compounds and protein according to the literature mining and computational prediction results.
Target-pathway network: The interactions in the "target-pathway" network were selected from the pathway enrichment results.
Degree distribution of the network: The sizes of the nodes correspond to the node degree. In a network, the degree k of a node is the number of edges linked to that node. The degree distribution P (k) of a network is the frequency of occurrence of nodes with degree k, (k = 1, 2,…).
Pathway enrichment: P values were used to determine if a specific pathway in the KEGG database was more enriched with the related proteins than by chance. Assuming that a total of K proteins related to the 25 constituents of SBP were mapped into KEGG, which contains N distinct proteins and k proteins from a pathway of size n are related to the GTPs, P value is given by
The two-sided hypergeometric test and the Bonferroni correction were used. 
Results
Data preparation
To collect targets information for 25 constituents of SBP comprehensively, we did not only collect confirmed targets through searching PubMed and CTD but collected the most potent targets by similarity searching and reverse docking. Similar Property Principle suggested that structurally similar molecules should exhibit the same (or similar) bioactivities. [24] Based on this entrenched assumption, the top-ranked similar molecules in a biological structure query are likely to possess the same activity profiles and may be regarded as the prime candidates for pharmacological tests. [25] This method has been regarded as one of the most powerful tools in the medicinal chemists' toolkit. [26] Reverse docking is a novel technology that allows the docking of a compound with a known biological activity into the binding sites of all of the 3D structures in a given protein database. The PharmMapper server is a freely accessed web server designed to identify potential target candidates for a specific small molecule probe (drugs, natural products, or other newly discovered compounds with unidentified binding targets) using the pharmacophore mapping approach. [21] It is backed up Higher research level should result in more target information. In addition, the structural complexity of compounds increases the difficulty of reverse docking and similarity searching. Simultaneously, most of the targets can be targeted by more than one constituents [ Figure 2 ].
Shexiang Baoxin pill-regulated coronary heart disease network
After searching the DrugBank database, 322 drugs and 490 protein targets [ Table S2 ] that related to coronary heart disease were extracted. The coronary heart disease network was constructed by mapping the 490 targets into the String database. After excluding isolated nodes, the protein interaction network induced by SPB components was composed of 488 nodes (proteins) and 3919 edges (interactions) [ Figure 3a ]. The topological properties of the network were analyzed with the network analyzer plugin. Among these properties, the node degree distribution was in accordance with a power law, indicating that the constructed network is scale free and does not present a random topology [ Figure S1 ]. The SBP-regulated coronary heart disease network was constructed by mapping the 330 protein targets from literature mining and computational prediction into the coronary heart disease network [ Figure 3 ]. Finally, we found that 52 proteins of 330 protein targets presented in coronary heart disease network [ Figure 3c and d]. Moreover, 20 constituents of SBP could modulate this coronary heart disease network [ Figure 3 ].
Pathway enrichment
TCM usually exhibits diverse bioactivities by mediating multiple pathways, so it is reasonable to analyze the potential pathways. In this study, pathway enrichment based on the hypergeometric test was utilized to analyze the potential pathways mediated by the SBP. Ultimately, 171 KEGG pathways were identified and 31 of these were found to be more enriched (P < 0.01) [ Tables 2 and S3 ]. Three pathways (hsa04976, hsa04960, and hsa04370) of them caught our attention because they related with coronary heart disease. Hsa04976 pathway controls the bile secretion and related with hyperbilirubinemia. Previous research has proved that coronary heart disease is closely related to the level of bilirubin in the blood. Low bilirubin content can exacerbate the incidence of coronary heart disease and increasing of bilirubin content could decrease the incidence of coronary heart disease. [27] Bilirubin and bile acids can compensate for each other in the body. [28] While Cholic acid regulate the synthesis of bile acids through negative feedback. [29] The cholic acid-type compounds [5] [6] [7] 19 ] from SBP may mimic the role of bilirubin to cure coronary heart disease, but the mechanism need confirm. As showed in Figure 4 , 15 proteins (NTCP, OCT1, CYP7A1, SHP, FXR, RXRa, UGT2B4, CYP3A4, ABCG5, ABCG8, BSEP, MRP2, MDR1, MDR3, and CA) in the bile secretion pathway can be modulated by the constituents of SBP [ Figure 4 ].
Aldosterone-regulated sodium reabsorption pathway (hsa04960) can influence human blood pressure by regulating epithelial sodium ion channels. [30] Studies have shown that inhibition of sodium ion channel can lower blood pressure.
[31] Coincidently, hypertension is a major cause of coronary heart disease.
[32] Five proteins (IRS1, ATPase, ERK1/2, MR, and 11b-HSD2) in this pathway can be affected by constituents of SBP [ Figure 5 ]. Among them, the ATPase regulating sodium and potassium exchange can be targeted by the compounds bufalin (1), 3-epi-bufalin (3), 1-hydroxybufalin (17) , and gamabufotalin (23) [ Figure 5 ].
Vascular endothelial growth factor signaling pathway (Hsa04370) can promote the survival, migration, and proliferation of vascular endothelial cells through activating the Akt signaling pathway, and thereby regulating the formation of vascular endothelium and endocardium, which are all associated with coronary heart disease.
[33] Eleven proteins in this pathway can be targeted by SBP constituents [ Figure 6 ].
dIscussIon
TCM is a type of holistic, natural health-care system because it stimulates the body's own healing mechanisms and takes into account all aspects of a patient's life, rather than just several obvious signs or symptoms. TCM practitioners view the body as a complex network of interconnected parts, rather than separate systems or organs. Chinese herbal medicine, especially Chinese herbal formula, is one of the most important therapies in TCM. Formulas allow you to blend herbs to enhance their positive effects and reduce or eliminate any negative side effects they may have. The formulas take years and years of practice to master and many are kept within families and/or generations of teacher-student transmissions. Therefore, they are a very valuable medical gift from the previous generations. However, some, particularly in the West, doubt the effect and synergy of TCM as its mechanisms are less definitive than Western-style scientific medicine. Understanding the scientific basis of herbal formulae at the molecular level and from a systems perspective is still one of the great challenges for evidence-based TCM. Network pharmacology links the multiple components that play principal, complementary, and assistant therapeutic roles in TCM formulae to the principal, complementary, and assistant targets in a disease network. [10, 34] This approach offers a novel philosophical guide and technological route to designing and understanding mechanisms of action of TCM drugs through projecting a TCM drug component network onto a disease network. [11] Coronary heart disease has many causes. SBP is a classic TCM formula that can effectively treat the coronary heart disease. Therefore, it is reasonable that to analyze the mechanism of SBP for treating coronary heart disease from a holistic view. In this study, the method of network pharmacology was utilized to analyze the mechanism of SBP systematically. First, we focused on the 26 blood constituents of SBP and collected all available targets of them. Second, "drugs-targets" and "targets-targets" networks were constructed. Third, the disease-target network was constructed. Finally, we analyzed the mechanism of SBP by mapping the component network onto the disease network and pathway enrichment. After this work, the SPB-modulated coronary heart disease network was constructed, in which 20 constituents of SBP could modulate the coronary heart disease network. Moreover, three key pathways that related to the coronary heart disease network were identified. In this process, the network pharmacology method is very suitable for a comprehensive analysis of the mechanism of SBP in treating coronary heart disease. However, our work still has some drawbacks. First, target information is not enough just through literature mining and computational prediction. In the future work, the experimental targets should be identified and added to this work. Second, the targets information identified by literature mining and computational prediction has a bias. Small molecules that are more studied tend to have more target information. In addition, the computational prediction will generate more target information for simpler small molecules than molecules with more complicated structure. In a brief, the target information should not only come from literature mining and computational prediction but also need to collect more experimental targets information.
conclusIon
In summary, the mechanism of SBP treating for coronary heart disease was analyzed systematically using network pharmacology in this study. Finally, we constructed the disease network of coronary heart disease and identified 20 blood constituents of SBP that can modulate this network. Moreover, three pathways relating to coronary heart disease were identified. In addition, this research study provides comprehensive and useful data for more in-depth studies of mechanisms of SBP. 
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LGALS3 LPL ABCC2  13  HRAS TTR CRABP2  14  MAPK14 TTR MET HEXB APP BAD PLCG1 IL1B MAPK1 MAPK3 NFE2L2 NFKBIA NOS2 PTGS2  15  TGM3 HEXB  16  TGM3 HEXB  17  HSD17B1 VDR ATP12A ATP1B2 ATP1B1 ATP1B3 ATP1A3 ATP1A1 ATP1A4  18  RBP4 OPRK1 OPRM1 OPRD1 TNFRSF1A CA2 CA1 MAOA ALDH2 HSD11B1 SENP8 SENP6 SENP7 CASP3 TUBB4A TUBB1  TUBB TUBB4B TUBB3 TUBB8 LIPE DRD2 VDR DRD3 TDP1 THRB ESR1 ESR2 NEFH TFF1  19  RBP4 VDR CYP17A1 FABP1 GPBAR1 TDP1 DRD3 DRD2 NR1H4  20  ALDH1A1 NFATC1 TRPA1  21  PTPN1 GLO1 FKBP1A EIF4G1 MMP9 MMP3 ADAM17 PPME1 ALPL PLAA ALPI ALOX5 CA1 CA9 CA2 ESR1 AKR1B1 SYK  CAT TYR CYP17A1 CYP2A6 CYP2C19 CYP2C8 CYP2C9 CYP2D6 CYP2E1 CYP3A4  22  TTR RARG RORA VDR RBP4 MAP2K1 RXRB SHBG CYP17A1 CYP19A1  23  ATP1A1  24  TRPA1 GRIN1 GRIN2B UGT2B7 ADRA2C ADRA1D ADRA2A SIGMAR1 APOBEC3G APOBEC3A GRIN2C GRIN3B GRIN3A  SLC22A1 GRIN2D GRIN2A  25 MET TOP1 TOP2A Table S2 : Drugs associated with coronary heart disease and related targets from Drugbank database Drugbank ID Targets   DB00119  PKLR PKM2 PDHB AGXT2 SLC16A6 SLC16A2 SLC16A4 ABAT SLC16A8 SLC16A5 SLC16A7 SLC16A3 SLC16A1 PC  DB00122  ACHE PCYT1B PCYT1A PLD2 BCHE PLD1 PHOSPHO1  DB00125  NOS2 SLC7A4 SLC7A3 SLC7A1 NOS3 ADC ASL ASS1 ASS1 argG argG ARG2  DB00132  FADS1 SLC8A1 TRPV1 FADS2 ELOVL4  DB00140  RFK BLVRB ribE  DB00141  RENBP B4GALT1 NAGLU B4GALT3 B4GALT4 B4GALT2 NAGK NAGPA  DB00146  VDR  DB00148  CKB CKMT1A SLC6A8 CKMT2 GAMT CKM  DB00152  TPK1 SLC19A2  DB00155  NOS2 NOS1 NOS3 OTC DDAH2 ASS1 ASS1 argG argG DDAH1 ASS1 ASS1 argG argG PADI4 PADI6 PADI1 PADI3 PADI2  DB00157  HSD17B2 NNT ADH5 AMT IDH3A NDUFV3 DHCR7 NDUFS8 NSDHL HSD3B1 HSD3B2 DLAT LDHB AASS NDUFA10  NDUFS5 NDUFS6 SC4MOL PDHB LDHAL6B AKR1C1 HIBADH HSD11B2 ALDH2 ALDH7A1 NDUFV2 ME2 LDHC ALDH5A1  CYB5R3 PHGDH serA serA OGDH NDUFA4 NDUFC2 BDH1 GLUD1 HSD17B7 NDUFS3 ALDH3B2 HSD17B1 MT-ND3  GPD1 NDUFA6 NQO2 NDUFA1 PYCR1 ADH1A ALDH6A1 NDUFB5 ALDH4A1 NDUFB10 TYR HADHA MTHFD2 MT-ND4L  NDUFB3 ALDH9A1 NDUFB4 LDHAL6A SORD NDUFA9 NDUFS7 NDUFC1 HSD17B10 NDUFA4L2 ME3 HSD11B1 DHFR  DFR1 folA folA folA folA dfrA HSD17B3 NDUFB1 CYP17A1 MT-ND6 H6PD ADH4 NDUFA8 NDUFB6 HADH ADH1B NDUFA7  HSD17B4 CYP4A11 LDHA NDUFB2 AKR1C4 ALDH3B1 ADH1C NDUFA5 ALDH1B1 NDUFV1 NDUFS1 NDUFS4 MT-ND1  NDUFB7 ALDH1A2 ADH7 NDUFA13 QDPR NDUFA11 GAPDH gap gap gap NDUFAB1 NDUFA2 MT-ND4 HPGD ALDH1A1  IDH3B CDO1 RDH5 PDHA1 HMGCR mvaA HSD17B8 MT-ND5 ALDH1A3 EHHADH HMOX2 pbsA2 MDH1 AKR1C3 BLVRB  NDUFB9 ALDH3A2 ME1 PDHA2 MTHFD1 AKR1C2 UGDH hasB GSR MT-ND2 TSTA3 fcl NDUFB8 NDUFA3 ALDH3A1  GAPDHS IMPDH2 PYCR2 NDUFS2 HMOX1 pbsA1 DLD BLVRA AKR1B1 NDUFA12 GLUD2 IMPDH1 ACADS IDH3G MDH2   suppleMent table   Table S2 : Contd... Targets   DB00159  PTGS1 PPARG PTGS2 FFAR1 FADS1 SLC8A1 ACSL4 PPARD TRPV1 ACSL3  DB00163  SEC14L4 ALOX5 SEC14L2 SEC14L3 PRKCB NR1I2 PRKCA DGKA PPP2CB PPP2CA  DB00165  PDXK ALDH7A1 PDXP CBS  DB00172  P4HA1 EPRS PYCR1 SLC6A14 SLC6A7 PYCR2 PPIA ppiA PPIF PROSC LEPRE1 LEPREL1 LEPREL2 P4HA2 PRODH PPIH  PPIB PPIC PPIG P5CR2 PARS2  DB00173  APRT ACACB MTAP cobT mtnN ptd mutY PECR ruvB ruvB ACP1 SRPK2  DB00175  HMGCR mvaA  DB00176  SLC6A4  DB00177  AGTR1  DB00178  ACE  DB00181  GABBR1 GABBR2  DB00187  ADRB1  DB00188  PSMD1 PSMD2 PSMB1 PSMB5 PSMB2  DB00190  DDC  DB00195  ADRB1 ADRB2  DB00201  ADORA1 PDE4B RYR1 ADORA2A  DB00206  SLC18A2  DB00208  P2RY12  DB00209  CHRM1  DB00212  REN  DB00214  SLC12A1  DB00215  SLC6A4  DB00216  HTR1A HTR2B HTR1F HTR1E HTR7 HTR1D HTR1B  DB00224  HIV-1 protease  DB00226  SLC6A2  DB00227  ITGAL HMGCR mvaA HDAC2  DB00228  ATP2C1 GLRA1 ATP5D MT-ND1 KCNMA1 GRIA1 KCNA1 GABRA1  DB00232  CA1 CA2 SLC12A1 CA4  DB00235  PDE3A  DB00237  GABRA2 GABRA5 GABRA4 GABRA3 GABRA6 GABRA1 GRIK2 GRIA2 CHRNA4 CHRNA7  DB00243  SCN5A SCN9A  DB00264  ADRB1 ADRB2  DB00275  AGTR1  DB00280  CHRM3 CHRM1 SCN5A CHRM2 KCND2 KCND3  DB00281  SCN10A SCN5A EGFR SCN9A  DB00292  ADRA2B GABRA1  DB00296  SCN10A  DB00297  PTGER1 SCN10A  DB00313  ABAT ACADSB HDAC9  DB00321  CHRM3 CHRM1 CHRM5 ADRA2A HTR1A CHRM4 OPRD1 HRH1 HTR2A SLC6A2 ADRA1A CHRM2 OPRK1 ADRA1D  SLC6A4 KCNA1 KCNQ2 NTRK1 KCND2 KCND3 NTRK2  DB00325  NPR1  DB00335  ADRB1  DB00343  CACNG1  DB00344  SLC6A2 SLC6A4  DB00350  PTGS1 KCNJ1  DB00365  gyrA gyrA parC parC parC  DB00368  ADRB1 ADRA2A ADRA2C ADRA1A ADRA2B ADRA1B ADRB2 ADRA1D PAH phhA ADRB3  DB00373  ADRB1 ADRB2 E R 17  DB00374  P2RY12 PTGIR PPARD  DB00379  SCN5A AHR  DB00380  TOP2A TOP2B  DB00383  CHRM3 CHRM1 CHRM2  DB00384 SCNN1B SCNN1A SCNN1D SCNN1G
DrugBank ID
Contd... Targets   DB00385  TOP2A  DB00388  ADRA1A ADRA1B ADRA1D  DB00390  ATP1A1  DB00392  CHRM1 CHRM2 GRIN3A  DB00393  CACNB1 CACNA1C NR3C2 CACNB2 CACNA1S CACNB4 CACNA1F CACNB3 CACNA1D AHR  DB00401  CACNA1C CACNA2D1 CACNB2 CACNA1S CACNA1D  DB00405  HRH1  DB00412  PPARG ACSL4  DB00416  CHRNA2  DB00417  pbpA dacB mecA  DB00421  AR NR3C2  DB00424  CHRM3 CHRM1 CHRM4 CHRM2  DB00436  CA1 CA2 SLC12A3 CA4 KCNMA1  DB00445  CHD1 TOP2A  DB00457  KCNH2 KCNH6 ADRA1A ADRA1B KCNH7 ADRA1D  DB00458  CHRM3 CHRM1 CHRM5 CHRM4 HRH1 HTR2A SLC6A2 ADRA1A CHRM2 ADRA1D SLC6A4 KCND2 KCND3 snf  DB00462  CHRM3 CHRM1 CHRM2  DB00463  GABRA2 GABRA5 GABRA4 GABRA3 GABRA6 GABRA1 GRIK2 GRIA2 CHRNA4 CHRNA7  DB00470  CNR1 CNR2  DB00471  ALOX5 CYSLTR1  DB00473  SCN10A SCN5A  DB00477  DRD1 HTR1A HTR2A ADRA1A ADRA1B DRD2  DB00481  ESR1 ESR2  DB00482  PTGS2 PDPK1  DB00483  ACHE CHRM2 CHRNA2  DB00484  ADRA2A ADRA2C ADRA2B  DB00486  CNR1 CNR2  DB00489  KCNH2 ADRB1 ADRB2  DB00492  ACE  DB00494  COMT  DB00501  HRH2  DB00505  CHRM3 CHRM1 CHRM2  DB00508  DRD1 CHRM1 HTR2B CHRM2 DRD2  DB00510  ABAT  DB00511  ATP1A1  DB00517  CHRM3 CHRM1 CHRM2  DB00519  ACE  DB00521  ADRB1 ADRB2  DB00528  CACNG1  DB00540  CHRM3 CHRM1 CHRM5 HTR1A CHRM4 HRH1 HTR2A SLC6A2 ADRA1A CHRM2 ADRA1D SLC6A4  DB00542  ACE  DB00543  DRD1 CHRM1 ADRA2A SLC6A2 ADRA1A SLC6A4 DRD2 GABRA1  DB00555  SCN2A  DB00559  EDNRB EDNRA  DB00569  F10 SERPINC1  DB00571  ADRB1 HTR1A ADRB2 HTR1B ADRB3  DB00572  CHRM3 CHRM1 CHRM5 CHRM4 CHRM2  DB00575  ADRA2A ADRA2C ADRA2B  DB00579  SLC6A2 SLC6A3 SLC6A4  DB00583  SLC25A29 SLC22A5 CPT2 CROT CPT1A CRAT SLC25A20 SLC22A4  DB00584  ACE  DB00594  SCNN1B SCNN1A ABP1 ACCN2 SCNN1D SCNN1G ACCN1 SLC9A1 PLAU  DB00598  ADRB1 ADRA1A ADRA1B ADRB2  DB00602 GLRA3 GABRB3
Contd... Targets   DB00604  HTR4 KCNH2 HTR3A HTR2A  DB00606  FXYD2 CA1 CA2 CA4  DB00610  ADRA1A  DB00611  OPRD1 OPRK1 OPRM1  DB00612  ADRB1 ADRB2  DB00613  HNMT  DB00616  ACE MME  DB00622  CHRM3 CHRM1 CHRM5 CHRM4 CALM1 CACNA1C ADRA1A CHRM2 ADRA1B CACNA2D1 ADRA1D CACNB2 CACNA1D  PDE1B PDE1A  DB00629  ADRA2A  DB00633  ADRA2A  DB00640  ADORA1 ADORA2B ADORA3 ADORA2A  DB00645  SCN10A  DB00652  SIGMAR1 OPRK1 OPRM1  DB00659  GRIN3A GRM1 GRM2 GRM5 GRM3  DB00661  CACNA1I KCNH2 SCN5A CACNB1 CACNA1A CACNA1C CACNA1G KCNJ11 SLC6A4 CACNA1B CACNB2 CACNA1S  CACNB4 CACNA1F CACNB3 CACNA1D  DB00662  DB00668  ADRB1 ADRA2A ADRA1A ADRA2B ADRA1B ADRB2 ADRA1D PAH phhA  DB00670  CHRM1  DB00677  ACHE BCHE  DB00679  DRD1 KCNH2 HTR2A ADRA1A ADRA1B DRD2  DB00680  SCN5A  DB00682  VKORC1  DB00687  AR NR3C2 NR3C1  DB00691  ACE ACE2  DB00692  ADRA2A ADRA1A  DB00694  TOP2A TOP2B  DB00695  SLC12A1  DB00700  NR3C2  DB00706  ADRA1A ADRA1B ADRA1D  DB00722  ACE ACE2  DB00723  ADRA1A ADRA1B  DB00726  DRD1 HTR1A HRH1 HTR2A SLC6A2 ADRA1A ADRA2B ADRA1B SLC6A3 SLC6A4 DRD2  DB00727  NPR1  DB00731  ABCC8 PPARG  DB00732  CHRNA2  DB00736  ATP4A  DB00741  ANXA1 NR3C1  DB00743  DB00749  PTGS1 PTGS2 RXRA  DB00758  P2RY12  DB00761  SLC12A5 SLC12A6 SLC12A7 SLC12A2 SLC12A1 SLC12A4  DB00769  NR3C1  DB00770  PTGER1 PTGER2  DB00774  CA1 CA2 SLC12A1 CA4 KCNMA1 ATP1A1 CA12 CA9  DB00775  ITGA2B ITGB3  DB00777  DRD1 CHRM3 CHRM1 CHRM5 DRD4 CHRM4 HRH1 HTR2A ADRA1A HTR2C CHRM2 ADRA1B ADRA1D DRD2  DB00784  PTGS1 PTGS2  DB00788  PTGS1 PTGS2  DB00789  PGD  DB00790  ACE  DB00796 AGTR1
Contd... Targets   DB00804  CHRM1 CHRM2  DB00808  KCNE1 KCNQ1  DB00819  CA1 CA2 CA4 AQP1 CA3 CA7 CA14  DB00829  GABRR1 GABRA2 GABRA5 GABRA3 TSPO GABRA1 GABRB1 GABRB3 GABRB2 GABRG2 GABRG1 GABRG3 GABRE  GABRP GABRQ GABRR2 GABRD GABRR3  DB00830  SLC6A2 SLC6A3  DB00831  CALM1 ADRA1A CALY DRD2 TNNC1 S100A4  DB00835  CHRM3 CHRM1 CHRM5 CHRM4 HRH1 CHRM2  DB00841  ADRB1 ADRB2  DB00852  ADRB1 ADRA2A SLC6A2 ADRA1A SLC6A3 ADRB2 SLC6A4  DB00864  FKBP1A  DB00866  ADRB1 HTR1A ADRB2  DB00869  CA1 CA2 CA4  DB00871  ADRB2  DB00876  AGTR1  DB00880  CA1 CA2 SLC12A3 CA4  DB00881  ACE  DB00883  NPR1  DB00887  SLC12A5 SLC12A2 SLC12A1 SLC12A4 CFTR  DB00889  HTR3A  DB00909  CACNA1I SCN1A SCN11A SCN5A CA1 CA2 CACNA1G CA4 CACNA1H SCN9A CA12 SCN2A SCN3A SCN4A MAOB MAOA  CA9 CA3 CA5A CA5B CA7 CA8 CA10 CA11 CA13 CA14 SCN1B SCN2B SCN3B SCN4B  DB00912  ABCC8 PPARG  DB00914  PRKAA1 KCNJ8  DB00922  PDE3A KCNJ11 TNNC1 KCNJ8  DB00924  HTR2A  DB00930  DB00936  PTGS1 AKR1C1 PTGS2  DB00938  ADRB2  DB00940  CHRM1 HRH2  DB00945  PTGS1 AKR1C1 PTGS2  DB00953  HTR1F HTR1D HTR1B  DB00960  ADRB1 HTR1A ADRB2 HTR1B  DB00961  SCN10A  DB00964  ADRA2A ADRA1A  DB00966  AGTR1 PPARG  DB00968  ADRA2A  DB00975  PDE5A PDE10A PDE4A ADA  DB00981  ACHE  DB00983  ADRB2  DB00988  DRD1 DBH DRD5 DRD4 DRD3 SLC6A3 DRD2  DB00997  TOP2A  DB01001  ADRB1 ADRB2  DB01018  ADRA2A  DB01019  CHRM2  DB01020  GUCY1A2  DB01021  CA1 CA2 SLC12A1 CA4 ATP1A1  DB01029  AGTR1 JUN  DB01031  CA1 CA2  DB01035  SCN5A DNMT1  DB01048  DB01049  ADRA2A HTR1A ADRA1A SLCO2B1  DB01050 PTGS1 PTGS2
Contd... Targets   DB01054  CACNA1C CACNG1 CACNA2D1 CACNA1H CACNB2 CACNA1S CACNA1D CACNA2D2  DB01056  SCN5A  DB01064  ADRB1 ADRB2 MAPK1 PIK3R1 ADRB3 PIK3R2 PIK3R3  DB01069  CHRM3 CHRM1 CHRM5 CHRM4 CALM1 HRH1 HTR2A ADRA1A CHRM2 DRD2  DB01074  CPT2 CPT1A  DB01075  HRH1  DB01076  HMGCR mvaA DPP4 AHR  DB01078  ATP1A1  DB01081  OPRD1 OPRM1  DB01085  CHRM3 CHRM1 CHRM2  DB01089  SLC18A2  DB01092  ATP1A1  DB01093  DB01095  HMGCR mvaA  DB01098  HMGCR mvaA  DB01102  ADRB1 ADRB2 ADRB3  DB01103  PLA2G4A PLA2G6 PLCL1 plc  DB01104  SLC6A3 SLC6A4  DB01105  SLC6A2 SLC6A3 SLC6A4  DB01107  GABRA1  DB01109  F10 SERPINC1 SELP  DB01113  PDE4B PDE10A  DB01115  CALM1 CACNA1C CACNA2D1 KCNA1 CACNA1H CACNB2 CACNA1S CACNA1D  DB01118  KCNH2 ADRB1 CACNA1H CACNA2D2  DB01122  ACHE  DB01136  KCNH2 VEGFA ADRB1 NDUFC2 ADRA1A ADRB2 NPPB GJA1 VCAM1  DB01148  CHRM1 CHRM2  DB01149  ADRA2A HTR1A HTR2A SLC6A2 ADRA1A HTR2C ADRA1B SLC6A3 SLC6A4  DB01151  CHRM3 CHRM1 ADRB1 CHRM5 CHRM4 HRH1 HTR2A SLC6A2 ADRA1A CHRM2 ADRB2 SLC6A4 SMPD1  DB01158  ATP1A1  DB01166  PDE3A  DB01170  SLC6A2  DB01175  CHRM1 HRH1 SLC6A2 ADRA1A SLC6A3 SLC6A4  DB01177  TOP2A  DB01182  KCNH2 SCN5A  DB01184  DRD3 DRD2  DB01191  HTR2C SLC6A4  DB01193  ADRB1 ADRB2  DB01195  SCN5A SCN4A  DB01197  ACE MMP2  DB01203  ADRB1 ADRB2  DB01207  TBXA2R TBXAS1  DB01209  OPRK1 OPRM1  DB01210  ADRB1 ADRB2  DB01211  rplJ  DB01214  ADRB1 ADRB2  DB01221  TACR1 GRIN3A DRD2  DB01225  F10 SERPINC1  DB01228  SCN5A  DB01240  P2RY12 PTGIS PTGIR  DB01244  CACNA1A CALM1 KCNQ1 ATP1A1 CACNA1H TNNC1 CACNA2D2 PDE1B PDE1A  DB01247 MAOB MAOA DB01274 ADRB2
Contd... Contd... Targets   DB01275  P4HA1 AOC3  DB01288  ADRB1 ADRB2 ADRB3  DB01291  ADRB1 ADRB2  DB01294  PTGS1 PTGS2  DB01295  ADRB1 ADRA1A ADRB2  DB01297  ADRB1  DB01303  ADORA1 PDE3A ADORA2A PDE4A  DB01319 HIV-1 protease DB01327 mrcB ponB mrcA ponA mrcA pbpA PON1 ftsI ftsI mrdA mrdA penA pbpA pbp2 pbpC DB01339 CHRNA2  DB01340  ACE  DB01347  AGTR1  DB01348  ACE  DB01349  AGTR1 AGTR2  DB01353  GABRA2 GABRA5 GABRA4 GABRA3 GABRA6 GABRA1 GRIK2 GRIA2 CHRNA4 CHRNA7  DB01359  ADRB1 ADRB2  DB01364  SLC18A2 ACHE SLC6A2 ADRA1A  DB01365  ADRA1A  DB01366  ADRB2  DB01377  DB01384  NR3C1  DB01396  ATP1A1  DB01411  TNF CYSLTR1 RNASE3 MUC2 NFKB1 IL5  DB01412  ADORA1 PDE4B ADORA2A  DB01418  VKORC1  DB01426  SCN5A  DB01427  PDE3A PDE4B TNF  DB01577  SLC18A2 ADRA2A ADRA2C SLC6A2 ADRA2B SLC6A3 SLC6A4 TAAR1 MAOB MAOA  DB01578  DB01580  ADRB1 ADRB2  DB01608  DRD1 ADRA2A ADRA1B  DB01611  TLR7 TLR9  DB01612  NPR1  DB01614  DRD1 HTR1A HTR2A ADRA1A ADRA1B DRD2  DB01616  HTR1A  DB01626  MAOB MAOA  DB01628  PTGS2  DB04841  CACNA1I CALM1 HRH1 CACNA1G CACNA1H  DB04861  ADRB1 ADRB2  DB04880  PDE3A  DB04948  ADRA2A  DB06262  ADRB1 ADRA2A ADRA2C ADRA1A ADRA2B ADRA1B ADRB2 ADRA1D PAH phhA ADRB3  DB06268  EDNRB EDNRA  DB06700  SLC6A2 SLC6A4  DB06705  DB06712  CACNA1C CACNA2D1 CACNB2 CACNA1S CACNA1D CACNA2D3  DB06714  SLC18A2 TAAR1  DB08803  DB08807  ADRB1 HTR1A ADRB2 HTR1B ADRB3  DB08808 ADRB1 ADRB2 ADRB3 Ubiquinone and other terpenoid-quinone biosynthesis 1 1.00E+00 1.00E+00 1.00E+00 hsa00480
Glutathione metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa03410
Base excision repair 1 1.00E+00 1.00E+00
1.00E+00 hsa05110
Vibrio cholerae infection 1 1.00E+00 1.00E+00 1.00E+00 hsa00270
Cysteine and methionine metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00071
Fatty acid metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00531
Glycosaminoglycan degradation 1 1.00E+00 1.00E+00 1.00E+00 hsa04940
Type I diabetes mellitus 1 1.00E+00 1.00E+00 1.00E+00 hsa05100
Bacterial invasion of epithelial cells 1 1.00E+00 1.00E+00 1.00E+00 has00280
Valine, leucine, and isoleucine degradation 1 1.00E+00 1.00E+00 1.00E+00 hsa00010 Glycolysis/gluconeogenesis 1 1.00E+00 1.00E+00 1.00E+00 hsa00310
Lysine degradation 1 1.00E+00 1.00E+00 1.00E+00 Hsa00520
Amino sugar and nucleotide sugar metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00592
Alpha-linolenic acid metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa03040 Spliceosome 1 1.00E+00 1.00E+00 1.00E+00 hsa04514 CAMs 1 1.00E+00 1.00E+00 1.00E+00 hsa00120
Primary bile acid biosynthesis 1 1.00E+00 1.00E+00 1.00E+00 hsa00511
Other glycan degradation 1 1.00E+00 1.00E+00 1.00E+00 hsa04614
Renin-angiotensin system 1 1.00E+00 1.00E+00 1.00E+00 hsa00740
Riboflavin metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa04710
Circadian rhythm -mammal 1 1.00E+00 1.00E+00 1.00E+00 hsa00410
Beta-alanine metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00190
Oxidative phosphorylation 1 1.00E+00 1.00E+00 1.00E+00 hsa05150
Staphylococcus aureus infection 1 1.00E+00 1.00E+00 1.00E+00 hsa00640
Propanoate metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00603
Glycosphingolipid biosynthesis -globo series 1 1.00E+00 1.00E+00 1.00E+00 hsa00604
Glycosphingolipid biosynthesis -ganglio series 1 1.00E+00 1.00E+00 1.00E+00 hsa00232
Caffeine metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa04640
Hematopoietic cell lineage 1 1.00E+00 1.00E+00 1.00E+00 hsa00630
Glyoxylate and dicarboxylate metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa05130
Pathogenic Escherichia coli infection 1 1.00E+00 1.00E+00 1.00E+00 hsa00052
Galactose metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00051
Fructose and mannose metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa04145 Phagosome 1 1.00E+00 1.00E+00 1.00E+00
Contd... Ribosome biogenesis in eukaryotes 1 1.00E+00 1.00E+00 1.00E+00 hsa04966
Collecting duct acid secretion 1 1.00E+00 1.00E+00 1.00E+00 hsa05332
Graft-versus-host disease 1 1.00E+00 1.00E+00 1.00E+00 hsa00260
Glycine, serine, and threonine metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa00450
Selenocompound metabolism 1 1.00E+00 1.00E+00 1.00E+00 hsa04070
Phosphatidylinositol signaling system 1 1.00E+00 1.00E+00 1.00E+00 hsa03420
Nucleotide excision repair 1 1.00E+00 1.00E+00 1.00E+00 hsa04976
Bile secretion 21 4.71E-17 1.12E-14 1. 12E-14  ATP1B3  CYP3A4  NR0B2  SLC10A1  ABCB11  UGT2B4  ATP1B2  ATP1B1  NR1H4  ATP1A1  RXRA  CA2  ABCC2  CYP7A1  ATP1A2  ABCB1  ABCB4  SLC22A1  ABCG8  ATP1A3  ABCG5  hsa00982 Drug metabolism -cytochrome P450 18 3.26E-13 7.73E-11 3. 86E-11  UGT2B15  CYP3A4  CYP2C19  CYP2A6  UGT1A4  UGT1A7  UGT2B17  UGT2B4  UGT2B10  CYP2D6  UGT1A1  UGT2B7  UGT1A8  UGT1A10  CYP2E1  MAOA  CYP2C9  CYP2C8 Contd... CYP3A4  HSD17B1  UGT1A4  UGT1A7  UGT2B17  UGT2B4  UGT2B10  CYP19A1  CYP17A1  HSD11B1  UGT1A1  UGT2B7  CYP7A1  UGT1A8  UGT1A10  hsa00830 Retinol metabolism 16 2.95E-12 6.99E-10 1. 75E-10  UGT2B15  CYP3A4  CYP2C19  CYP2A6  UGT1A4  UGT1A7  UGT2B17  UGT2B4  UGT2B10  UGT1A1  UGT2B7  ALDH1A1  UGT1A8  UGT1A10  CYP2C9  CYP2C8  hsa00040 Pentose and glucuronate interconversions 12 1.50E-11 3.56E-09 7. 12E-10  UGT2B15  UGT1A4  UGT1A1  UGT1A7  UGT2B7  UGT2B17  UGT1A8  ALDH2  AKR1B1  UGT1A10  UGT2B4  UGT2B10  hsa00053 Ascorbate and aldarate metabolism 11 3.44E-11 8.16E-09 1.36E-09 UGT2B15 UGT1A4
Contd... CYP3A4  CYP2C19  UGT1A4  UGT1A7  UGT2B17  UGT2B4  UGT2B10  UGT1A1  UGT2B7  UGT1A8  UGT1A10  CYP2E1  CYP2C9  CYP2C8  hsa05014  ALS  13  8.34E-10  1.98E-07  2.37E-08  GRIN2B  GRIN2C  GRIN1  CAT  MAPK14  BAX  GRIN2D  GRIN2A  BAD  TNFRSF1A  BCL2  CASP3  NEFH  hsa00860 Porphyrin and chlorophyll metabolism 12 9.00E-10 2.13E-07 2. 37E-08  UGT2B15  FECH  UGT1A4  UGT1A1  UGT1A7  UGT2B7  UGT2B17  HMOX1  UGT1A8  UGT1A10  UGT2B4  UGT2B10  hsa04960 Aldosterone-regulated sodium reabsorption 11 4.00E-09 9.48E-07 9.48E-08
Contd... CYP3A4  CYP2A6  UGT1A4  UGT1A7  UGT2B17  UGT2B4  UGT2B10  UGT1A1  UGT2B7  UGT1A8  UGT1A10  hsa04722 Neurotrophin signaling pathway 17 3.90E-08 9.24E-06 7. 70E-07  MAPK8  AKT1  NFKBIA  BAX  PRKCD  PLCG1  RELA  BCL2  NGFR  HRAS  MAPK3  NGF  MAPK1  MAPK14  IRS1  BAD  MAP2K1  hsa04080 Neuroactive ligand-receptor interaction 25 8.24E-08 1.95E-05 1. 50E-06  GRIN2B  ADRA2A  DRD2  THRB  CHRM5  OPRK1  GRIN2D  GLRA2  DRD3  GABRB1 Contd... Contd... AKT1  NFKBIA  IL8  ICAM1  RELA  MAPK3  MAPK1  MAPK14  IL1B  TNFRSF1A  MAP2K1  hsa04724 Glutamatergic synapse 10 2.64E-03 6.25E-01 9.32E-03 PLA2G1B GRIN2B GRIN3B GRIN2C GRIN3A MAPK3
Contd... Ubiquinone and other terpenoid-quinone biosynthesis 1 1.00E+00 1.00E+00 1.00E+00 TAT hsa00480
Glutathione metabolism 1 1.00E+00 1.00E+00 1.00E+00
Contd... Vibrio cholerae infection 1 1.00E+00 1.00E+00 1.00E+00 PLCG1 hsa00270
Cysteine and methionine metabolism 1 1.00E+00 1.00E+00 1.00E+00 TAT hsa00071
Fatty acid metabolism 1 1.00E+00 1.00E+00 1.00E+00 ALDH2 hsa00531
Glycosaminoglycan degradation 1 1.00E+00 1.00E+00 1.00E+00 HEXB hsa04940
Type I diabetes mellitus 1 1.00E+00 1.00E+00 1.00E+00 IL1B hsa05100
Bacterial invasion of epithelial cells 1 1.00E+00 1.00E+00 1.00E+00 MET hsa00280
Valine, leucine, and isoleucine degradation 1 1.00E+00 1.00E+00 1.00E+00 ALDH2 hsa00010
Glycolysis/gluconeogenesis 1 1.00E+00 1.00E+00 1.00E+00 ALDH2 hsa00310
Lysine degradation 1 1.00E+00 1.00E+00 1.00E+00 ALDH2 hsa00520
Amino sugar and nucleotide sugar metabolism 1 1.00E+00 1.00E+00 1.00E+00 HEXB hsa00592
Alpha-linolenic acid metabolism 1 1.00E+00 1.00E+00 1.00E+00 PLA2G1B hsa03040 Spliceosome 1 1.00E+00 1.00E+00 1.00E+00 NHP2L1 hsa04514 CAMs 1 1.00E+00 1.00E+00 1.00E+00 ICAM1 hsa00120
Primary bile acid biosynthesis 1 1.00E+00 1.00E+00 1.00E+00 CYP7A1 hsa04614
Renin-angiotensin system 1 1.00E+00 1.00E+00 1.00E+00 AGT hsa00511
Other glycan degradation 1 1.00E+00 1.00E+00 1.00E+00 HEXB hsa00740
Riboflavin metabolism 1 1.00E+00 1.00E+00 1.00E+00 TYR hsa04710
Circadian rhythm -mammal 1 1.00E+00 1.00E+00 1.00E+00 RORA hsa00410
Beta-alanine metabolism 1 1.00E+00 1.00E+00 1.00E+00 ALDH2 hsa00190
Oxidative phosphorylation 1 1.00E+00 1.00E+00 1.00E+00 ATP12A hsa05150
Staphylococcus aureus infection 1 1.00E+00 1.00E+00 1.00E+00 ICAM1 hsa00640
Propanoate metabolism 1 1.00E+00 1.00E+00 1.00E+00 ALDH2 hsa00603
Glycosphingolipid biosynthesis -globo series 1 1.00E+00 1.00E+00 1.00E+00 HEXB hsa00604
Glycosphingolipid biosynthesis -ganglio series 1 1.00E+00 1.00E+00 1.00E+00 HEXB hsa00232
Caffeine metabolism 1 1.00E+00 1.00E+00 1.00E+00
Contd... Ribosome biogenesis in eukaryotes 1 1.00E+00 1.00E+00 1.00E+00 NHP2L1 hsa04966
Collecting duct acid secretion 1 1.00E+00 1.00E+00 1.00E+00 CA2 hsa05332
Graft-versus-host disease 1 1.00E+00 1.00E+00 1.00E+00 IL1B hsa00260
Glycine, serine, and threonine metabolism 1 1.00E+00 1.00E+00 1.00E+00 MAOA hsa00450
Selenocompound metabolism 1 1.00E+00 1.00E+00 1.00E+00 CCBL1 hsa04070
Phosphatidylinositol signaling system 1 1.00E+00 1.00E+00 1.00E+00 PLCG1 hsa03420
Nucleotide excision repair 1 1.00E+00 1.00E+00 1.00E+00 PCNA CAMs: Cell adhesion molecules, ASL: Amyotrophic lateral sclerosis, VEGF: Vascular endothelial growth factor
